Growth in the European diabetes care device market over the forecast period will be fueled by the rapidly growing diabetes patient population in the region and by a number of new product launches that will generate significant market revenues. The opportunities presented in the diabetes care device market are encouraging companies to invest in R&D and to partner with digital technology companies to develop new products that provide improvements for patients.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for diabetes care devices in Europe across a 10-year period.
The growth rate of diagnosed prevalent cases of diabetes is lower in Europe than in the US.
How quickly will diagnosed prevalent cases of diabetes grow in Europe?
How large will this population be by 2027?
There is a great deal of innovation in the European diabetes care market, including the launch of the first hybrid closed-loop "artificial pancreas."
Which markets will be the most impacted by new technology, and how will these innovations affect market trends?
Which new products are in development and when are they likely to enter the market?
The insulin delivery device market is large and will continue to expand rapidly through 2027.
What factors are driving growth in this market?
Which types of devices are seeing the strongest adoption, and how are these trends affecting other product segments?
Product preferences vary significantly by country.
How is reimbursement affecting product adoption in each country and in what markets is reimbursement expected to change?
- Diabetes Care Devices - Market Insights - Europe
Author(s): P Prasad, MS
Prasad Pallemsetty is a team lead within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Decision Resources Group, specializing in the fields of gastroenterology, bariatrics, diabetes, ENT and bronchoscopy, gynecology, and urology. In particular, he has extensive knowledge of endoscopic devices, laparoscopic devices, and minimally invasive procedures. Prasad has attended many international conferences, including ENDOCON 2016 in Mumbai and Diabetes India 2018 in Kolkata, where he gained insight into the latest trends in endoscopic gastroenterology and diabetes treatments, respectively. Prasad holds a Bachelor’s degree in Pharmacy and a Master’s degree in Pharmaceutics.
Follow Prasad on Twitter: @PPrasad_DRG